To Main Menu ► 

September 2016 Newsletter

//September 2016 Newsletter

Tandem gets FDA clearance for remote software update tool

By | September 16th, 2016|September 2016 Newsletter|

Wouldn't it be great to be able to get a software update to your existing insulin pump when your pump company comes out with new innovations rather than having to wait until your pump is out of warranty and you are due for a new pump? It's frustrating when you want the latest and greatest version but have to wait. Fantasy should be becoming reality sooner than you think.

Improvements in New Microneedle device for Type 2 diabetes

By | September 16th, 2016|September 2016 Newsletter|

There is some early research on Type 2 patients showing that a novel way of administering insulin may give better insulin coverage of meals and help to provide better after meal blood glucose (BG) control in Type 2 patients. In the future, it's possible that we could all be giving insulin in a different way than we do now. For details, read on!

Support Omnipod’s Pursuit of Medicare Coverage

By | September 16th, 2016|September 2016 Newsletter|

Help make sure people with diabetes have access to the equipment they need once they begin Medicare coverage.  A few clicks is all it takes to support this important effort. The Omnipod tubeless insulin pump has changed the lives of thousands of people living with diabetes. This system was cleared by the FDA over 10 years ago and is still the only FDA-cleared insulin delivery device NOT reimbursed by Medicare.  As a result, many stand to lose access to the Omnipod system when they transition from private health insurance and into Medicare. Recently, several prestigious organizations have joined in the effort to ensure that people with diabetes don’t lose access to the Omnipod® Insulin Management System once they are no longer covered by private insurance. These include: American Diabetes Association American Association of Clinical Endocrinologists American Association of Diabetes Educators Endocrine Society Juvenile Diabetes Research Foundation Now, you can join the cause.  And all it takes is TWO CLICKS.  You can quickly and easily engage your Members of Congress who serve on the committees that are most influential with the Centers for Medicare and Medicaid Services (CMS), the federal agency responsible for Medicare.  Click here to send a letter.  A suggested letter has already been written that you can edit if you wish.  All you need to do is enter your name, email and address, and the online service will automatically email your letter to the appropriate offices.  If you don’t think this can make a difference, you’re quite mistaken.  Many healthcare policies have been changed and improved through this type of “grass roots” effort.  Your personal involvement in this effort can make a real difference!

Finding a diabetes clinical trial just got a whole lot easier

By | September 16th, 2016|September 2016 Newsletter|

Have you ever wanted to participate in a clinical trial for diabetes so you could play a role in the development of a new product or make a contribution to our body of knowledge about the cure/prevention/treatment of diabetes, but didn't know how to do it? The process is now much more user-friendly than it has ever been!

Incidence of death similar in DCCT/EDIC participants and the general population

By | September 16th, 2016|September 2016 Newsletter|

The participants in the DCCT's conventional therapy group have significantly higher mortality, but those who had intensive control are faring much better. What does the latest evidence from a study published online on July 13 in Diabetes Care show?